Chris Verslype
Impact in
- Hepatology top 0.05%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
- Liver physiology and pathology
- Oncology top 0.1%
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
Papers in
- Hepatology 127
- Hepatocellular Carcinoma Treatment and Prognosis 65
- Liver Disease and Transplantation 33
- Oncology 105
- Pancreatic and Hepatic Oncology Research 31
- Lung Cancer Research Studies 30
- Colorectal Cancer Treatments and Studies 27
- Co-authors
- Eric Van Cutsem (89 shared papers)Yves Humblet (7 shared papers)Ian Chau (4 shared papers)Frederik Nevens (92 shared papers)David Khayat (3 shared papers)Harry Bleiberg (2 shared papers)David Cunningham (1 shared paper)A. Harstrick (1 shared paper)
- Journals
- Journal of Clinical Oncology (36 papers)Annals of Oncology (22 papers)Journal of Hepatology (18 papers)European Journal of Gastroenterology & Hepatology (9 papers)Hepatology (8 papers)
- Partner nations
- BelgiumUnited StatesGermany
In The Last Decade
Chris Verslype
329 papers receiving 15.7k citations
Chris Verslype's Hit Papers
Peers
Comparison fields: 5 of 154
- Hepatology 5.4k
- Oncology 6.2k
- Cancer Research 1.7k
- Pulmonary and Respiratory Medicine 2.8k
- Epidemiology 2.8k
Countries citing papers authored by Chris Verslype
This map shows the geographic impact of Chris Verslype's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Verslype with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Verslype more than expected).
Fields of papers citing papers by Chris Verslype
This network shows the impact of papers produced by Chris Verslype. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Verslype. The network helps show where Chris Verslype may publish in the future.
Co-authors
The 25 scholars most cited alongside Chris Verslype, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 343 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer Hit paper breakdown → | 2004 | 4041 |
| 2 | Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Hit paper breakdown → | 2018 | 734 |
| 3 | Phase III Trial of Gemcitabine Plus Tipifarnib Compared With Gemcitabine Plus Placebo in Advanced Pancreatic Cancer Hit paper breakdown → | 2004 | 647 |
| 4 | Phase III Trial of Bevacizumab in Combination With Gemcitabine and Erlotinib in Patients With Metastatic Pancreatic Cancer Hit paper breakdown → | 2009 | 530 |
| 5 | 2003 | 373 | |
| 6 | 2006 | 350 | |
| 7 | Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines Hit paper breakdown → | 2021 | 314 |
| 8 | 2012 | 310 | |
| 9 | 2008 | 299 | |
| 10 | 2010 | 289 | |
| 11 | 2007 | 268 | |
| 12 | 2012 | 250 | |
| 13 | Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma Hit paper breakdown → | 2019 | 249 |
| 14 | 2006 | 222 | |
| 15 | 2019 | 208 | |
| 16 | 2006 | 195 | |
| 17 | 2010 | 192 | |
| 18 | 2007 | 176 | |
| 19 | 2006 | 155 | |
| 20 | 2012 | 153 |
About Chris Verslype
Chris Verslype is a scholar working on Hepatology, Oncology, Epidemiology, Surgery and Pulmonary and Respiratory Medicine, having authored 343 papers that have together received 16.3k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (65 papers), Neuroendocrine Tumor Research Advances (47 papers), Liver Disease Diagnosis and Treatment (38 papers), Liver Disease and Transplantation (33 papers), Pancreatic and Hepatic Oncology Research (31 papers), Lung Cancer Research Studies (30 papers), Colorectal Cancer Treatments and Studies (27 papers) and Neuroblastoma Research and Treatments (23 papers). The work is most often cited by research in Hepatology (5.4k citations), Oncology (6.2k citations), Cancer Research (1.7k citations), Pulmonary and Respiratory Medicine (2.8k citations) and Epidemiology (2.8k citations). Chris Verslype has collaborated with scholars based in Belgium, United States and Germany. Frequent co-authors include Eric Van Cutsem, Yves Humblet, Ian Chau, Frederik Nevens, David Khayat, Harry Bleiberg, David Cunningham, A. Harstrick, M. Mueser and Armando Santoro. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Journal of Hepatology, European Journal of Gastroenterology & Hepatology and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.